GLP-1s and Muscle Loss - Part 2 Wegovy and Zepbound

from Weight and Healthcare · host Ragen Chastain

In Part 1 we looked at an early study of GLP1 drugs and muscle loss. Today we’ll look at two more recent studies, one for Eli Lilly’s drug tirzepatide and one for Novo Nordisk’s drug semaglutide. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

Episode metadata supplied by the publisher feed · Published Nov 8, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

GLP-1s and Muscle Loss - Part 2 Wegovy and Zepbound

0:00 10:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Weight and Healthcare?

This episode is 10 minutes long.

When was this Weight and Healthcare episode published?

This episode was published on November 8, 2025.

Can I download this Weight and Healthcare episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!